Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
A NOVEL research-cum-manufacturing agreement between Chiron Corp, the US-based vaccine major, and an Indian company for the development of a potential AIDS vaccine to halt the spread of the deadly disease in the country is in an advanced stage of finalisation. Two Hyderabad-based biotechnology...Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results
...Product Development, Contrave Program. Dr. Scaife has previously served as Senior Vice President of Global Safety, Regulatory Affairs and Quality for chiron Biopharma, and in similar roles with Nektar Therapeutics, Elan Pharmaceuticals and Novartis Biopharma. Jay Hagan as Senior Vice President of C...Sunesis Pharmaceuticals Appoints Helen S. Kim to Board of Directors
...tol-Myers Squibb in 2008. Ms. Kim's additional industry experience includes senior positions at Affymax, Onyx Pharmaceuticals, Protein Design Labs and chiron Corporation. In addition to her industry experience, Ms. Kim also recently served as Chief Program Officer for the Gordon and Betty Moore Foundation f...New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report
...ntarcia Therapeutics, Inc., Medivir AB, Merck & Co., Inc., Novartis AG, chiron Corporation, Pfizer, Inc., Schering-Plough Corporation, Tibotec Pharmaceuti... Merck & Co., Inc. (USA) II-75 Novartis AG (Switzerland) II-75 chiron Corporation (USA) II-75 Pfizer, Inc. (USA) II-76 Schering-Plough Co...Hospira Expands Board of Directors
... into the blood-screening market. From 1996 to 2000, von Prondzynski held several executive positions, including president of its vaccine business, at chiron Corporation, a multinational firm that develops biopharmaceuticals, vaccines and blood-testing products. Earlier in his career, von Prondzynski held s...Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008
... million, compared to $16.6 million in the prior year, an increase of 24% that resulted primarily from a $10 million milestone the Company earned from chiron in the third quarter based on the full approval by the US Food and Drug Administration (FDA) of the PROCLEIX ULTRIO assay on the TIGRIS system. ...Gen-Probe Reports Strong Financial Results for Third Quarter 2008, Raises Full-Year EPS Guidance
...ase resulted primarily from a $10 million milestone the Company earned from chiron based on the full approval by the US Food and Drug Administration (FDA) of ...riod, an increase of 33% that resulted primarily from higher royalties from chiron associated with the use of Gen-Probe's technologies in the plasma screening...Immune Design Announces $18 Million Series A Financing
...broaden protection across patient populations and minimize the amount of antigen required." Dr. Ed Penhoet, Partner at Alta Partners and former CEO of chiron Corporation will serve as Board Chairman. Other Board members include Dr. Richard Klausner, Partner in The Column Group, former Director of the Nation...Dr. Ronald E. Cape to Retire from EntreMed Board of Directors
...covery and development of the polymerase chain reaction (PCR), for which Cetus scientist Kary Mullis received the Nobel Prize. Cetus later merged with chiron Corporation. Dr. Cape was the founding chairman of Darwin Molecular Corporation, which was later sold to Chiroscience plc. He was also a founding memb...Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma
...unting from Rider College. Mr. Soland joined ViroPharma in 2006 as vice president and chief commercial officer from his previous job as president of chiron Vaccines. At Chiron, Mr. Soland was responsible for managing the vaccine division to annual sales of $1 billion. Prior to Chiron, he was the president...Rapid Flu Tests May Prove Especially Helpful This Season
... On October 5, chiron Corporation notified the CDC that none of its influenza vaccine (Fluvirin) would be available for distribution in the United States for the current in...H9N2 avian flu vaccine paired with adjuvant provokes strong human immune response at low doses
...from person to person, an influenza pandemic could result, health experts say. In 2004, NIAID directed Novartis Vaccines and Diagnostics (formerly chiron Corporation) to produce 40,000 doses of an experimental H9N2 vaccine at its vaccine manufacturing facility in Siena, Italy. Some of the vaccines were ...Report focuses on challenges to unlocking future promise of vaccines
...ailable for a given disease, numerous barriers can block its use, including technical, economic, cultural, and legal obstacles," says Rino Rappuoli of chiron SpA in Siena, Italy, another co-author of the report. ...Researchers predict infinite genomes
...tember 19-23) early online edition of the Proceedings of the National Academy of Sciences (PNAS). In the study, TIGR scientists, with collaborators at chiron Corporation, Harvard Medical School and Seattle Children's Hospital, compared the genomic sequence of eight isolates of the same bacterial species: S...NIAID Initiates Trial of Experimental Avian Flu Vaccine
...chester, NY (John Treanor, M.D., P.I.) In addition to the previous contract awarded to sanofi pasteur, in May 2004 NIAID also awarded a contract to chiron Corporation of Emeryville, CA, to produce H5N1 vaccine for clinical trials. ...Third Wave files patent suits against Digene, Chiron and Bayer
Madison, Wis. -- Third Wave Technologies Inc. has filed suit against three companies, seeking rulings regarding its right to sell two products, the company announced on Tuesday. The suits were filed in federal court in Madison. The company last Friday filed suit against Digene Corp., seeki...Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
...ein and antibody therapeutics in the areas of oncology, immunology and metabolic disease. Prior to that, Lorianne held senior leadership positions at chiron and Berlex, where she was instrumental in development of Betaseron(R) for relapsing forms of multiple sclerosis as well as numerous oncology programs....FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
...EIX ULTRIO assay, but that were initially negative based on serology tests for HBV surface antigen and core antibodies. In early 2007, Gen-Probe and chiron initiated post-marketing studies of the PROCLEIX ULTRIO assay to demonstrate the HBV yield required for a donor- screening claim. Based on the results...Pacira Pharmaceuticals, Inc. Adds Board Member and Key Senior Management
... in leading several product approvals through the FDA for both specialty pharmaceutical and medical device companies including; Artes Medical, Baxter, chiron Ophthalmics, and ICN Pharmaceucticals. (Logo: http://www.newscom.com/cgi-bin/prnh/20070618/PACIRALOGO ) Dr. Pace joins Pacira's six existing Boar...RainDance Appoints Kelly Chief Operating Officer
...e President, Clinical Operations and Worldwide Business, at PAREXEL International. He also served as Executive Director of Manufacturing Operations at chiron Diagnostics. Kelly received a Bachelor of Science degree in finance from Miami (Ohio) University and a Master of Business Administration degree from S...Adnavance Technologies Inc. Appoints Christian P. Valcke, Ph.D., to Its Scientific Advisory Board
...erves as the Senior Director of Instrument Systems at Novartis Vaccines and Diagnostics (NVS), a new division formed as a result of its acquisition of chiron Corporation. He was previously Vice President of Research and Development at Nanomix, a nanotechnology startup company. Prior to that, Dr. Valcke held...Medivation Announces Senior Management Promotions
...ronson held positions of increasing responsibility in regulatory affairs at chiron Corporation, including director in the oncology development organization, w...esponsible for approved products and developmental therapeutics. She joined chiron Corporation from SEQUUS Pharmaceuticals where she was responsible for the d...Kosan's Board of Directors Appoints Helen S. Kim as Chief Executive Officer
...e finance and strategic marketing. Ms. Kim's industry credentials include senior positions at Affymax, Onyx Pharmaceuticals, Protein Design Labs and chiron Corporation. At Affymax, she served as Chief Business Officer where she created and implemented a new business model and was responsible for portfolio...